GAM
MNTA

GQ Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

GQ Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$53K Buy
+1,955
New +$54.4K 0.1% 57

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

GQ Asset Management's MNTA Position: Q1 2020 in Review

GQ Asset Management opened a new position in Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2020: 1,955 shares worth $53K. The stake represents 0.1% of the portfolio and ranks #57 among its holdings.

199 funds tracked by Wall St. Rank hold MNTA as of Q1 2020.

  • GQ Asset Management held 1,955 shares of Momenta Pharmaceuticals, Inc. worth $53K as of Q1 2020.
  • Momenta Pharmaceuticals, Inc. was a new GQ Asset Management position in Q1 2020.
  • Momenta Pharmaceuticals, Inc. made up 0.1% of GQ Asset Management's portfolio in Q1 2020, its #57 holding.
  • 199 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2020.

Based on GQ Asset Management's 13F filing for Q1 2020, filed 8 May 2020.